John Ananda van Aalst
Medical Practice at Cincinnati Children's Hospital, 3333 Burnet Ave, Cincinnati, OH
License number
Kentucky 50102
Issued Date
Mar 16, 2017
Expiration Date
Feb 28, 2018
Category
Plastic Surgery
Type
Hospital Based
Address
Address
3333 Burnet Ave, Cincinnati, OH 45229
Education
Vanderbilt University School of Medicine, Nashville, 1993
Phone
(513) 636-0787 (Work)
Personal information
See more information about John Ananda van Aalst at radaris.comName
Address
Phone
9982 Mount Eaton Rd, Marshallville, OH 44645
266 Parrish Rd, Conneaut, OH 44030
30887 Barringer Ridge Rd, Portland, OH 45770
3033 Cinnamon Dr W, West Salem, OH 44287
2233 Olentangy Rd, Bucyrus, OH 44820
Professional information
See more information about John Ananda van Aalst at trustoria.com
Triazole Compounds Useful In Treating Diseases Associated With Unwanted Cytokine Activity
Triazole Compounds Useful In Treating Diseases Associated With Unwanted Cytokine Activity
US Patent:
6727364, Apr 27, 2004
Filed:
Apr 24, 2002
Appl. No.:
10/133044
Inventors:
Joshua Spector Tullis - Broomfield CO
John Charles Van Rens - Cincinnati OH
Michael Philip Clark - Loveland OH
Benjamin Eric Blass - Cincinnati OH
Michael George Natchus - Alpharetta GA
Biswanath De - Cincinnati OH
John Charles Van Rens - Cincinnati OH
Michael Philip Clark - Loveland OH
Benjamin Eric Blass - Cincinnati OH
Michael George Natchus - Alpharetta GA
Biswanath De - Cincinnati OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
C07D40104
US Classification:
5462684, 514340
Abstract:
The present invention relates to 4-aryl triazoles having the formula: wherein R is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR , SR , S(O)R , S(O) R , and NR R ; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.
Triazole Compounds Useful In Treating Diseases Associated With Unwanted Cytokine Activity
Triazole Compounds Useful In Treating Diseases Associated With Unwanted Cytokine Activity
US Patent:
6787555, Sep 7, 2004
Filed:
Apr 24, 2002
Appl. No.:
10/132981
Inventors:
Joshua Spector Tullis - Broomfield CO
John Charles Van Rens - Cincinnati OH
Michael Philip Clark - Loveland OH
Benjamin Eric Blass - Cincinnati OH
Michael George Natchus - Alpharetta GA
Biswanath De - Cincinnati OH
John Charles Van Rens - Cincinnati OH
Michael Philip Clark - Loveland OH
Benjamin Eric Blass - Cincinnati OH
Michael George Natchus - Alpharetta GA
Biswanath De - Cincinnati OH
Assignee:
The Procter Gamble Company - Cincinnati OH
International Classification:
A61K 31506
US Classification:
514275, 544316, 544328, 544331
Abstract:
The present invention relates to 4-aryl triazoles having the formula: wherein R is independently selected from the group consisting of: lower alkyl, lower alkenyl, lower alkynyl, lower heteroalkyl, lower heteroalkenyl, lower heteroalkynyl, heterocycloalkyl, heteroaryl, halo, CN, OR , SR , S(O)R , S(O) R , and NR R ; and Q is has the general formula: said compounds are useful in treating diseases associated with unwanted cytokine activity, inter alia, interleukin-1 (IL-1) and tumor necrosis factor (TNF) from cells.
Purine Cytokine Inhibitors
Purine Cytokine Inhibitors
US Patent:
7256196, Aug 14, 2007
Filed:
Dec 7, 2004
Appl. No.:
11/006095
Inventors:
Mark Sabat - Mason OH, US
Michael Philip Clark - Maineville OH, US
Todd Andrew Brugel - West Chester OH, US
Adam Golebiowski - Loveland OH, US
John Charles Van Rens - Cincinnati OH, US
Biswanath De - Cincinnati OH, US
Michael Philip Clark - Maineville OH, US
Todd Andrew Brugel - West Chester OH, US
Adam Golebiowski - Loveland OH, US
John Charles Van Rens - Cincinnati OH, US
Biswanath De - Cincinnati OH, US
Assignee:
The Procter & Gamble Company - Cincinnati OH
International Classification:
C07D 473/16, C07D 473/18, C07D 473/28, A61K 31/522, A61K 31/52
US Classification:
51426323, 544264, 544265, 544276, 544277, 544118, 544247, 5142633, 51426337, 51426338, 5142634
Abstract:
The present invention relates to 2,8,9-substituted purines which inhibit the extracellular release of inflammatory cytokines, said cytokines responsible for one or more human or higher mammalian disease states. The present invention further relates to compositions comprising said 2,8,9-substituted purines and methods for preventing, abating, or otherwise controlling enzymes which are understood to be the active components responsible for the herein described disease states.
Bottle
Bottle
US Patent:
D651093, Dec 27, 2011
Filed:
May 26, 2010
Appl. No.:
29/362477
Inventors:
John Charles Van Rens - Cincinnati OH, US
Assignee:
The Procter & Gamble Company - Cincinnati OH
International Classification:
0901
US Classification:
D 9541, D9543, D9569, D9571, D9575